QIAGEN OmicSoft and Biomedical Knowledge Base
Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and public single-cell data
272 views
Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to:
• View host immune response clusters across TCGA samples
• Identify differentially expressed immunomodulators across sample groups
• Visualize single-cell dimension reduction maps and overlay expression data
• Identify potential biomarkers whose expression correlates or anti-correlates with targets genes
• Validate new biomarkers using custom queries and TCGA survival data
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...
High-quality biomedical relationships knowledge is the cornerstone of modern...
QIAGEN OmicSoft and Biomedical Knowledge Base
Supercharge your AI in drug discovery with high-quality biomedical data
If you’re working in pharma or biotech, you likely rely on artificial...
QIAGEN OmicSoft and Biomedical Knowledge Base
Unlocking the power of API-based 'omics queries
If you're a data scientist or bioinformatician working in biopharma, here's...
QIAGEN OmicSoft and Biomedical Knowledge Base
Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation
If you’re a data scientist or bioinformatician working in biopharma and need...